Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

The Angels Initiative

Stroke prevention

  Parkinson's Disease

  Free Subscription


2 Ann Neurol
1 BMC Neurol
1 Int J Neurosci
1 J Neural Transm (Vienna)
1 J Neurosci
8 Mov Disord
1 Neurobiol Dis
4 Neurochem Res
1 Neurology
1 Neurosci Lett
1 PLoS One

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    Ann Neurol

  1. LIU H, Dehestani M, Blauwendraat C, Makarious MB, et al
    Polygenic resilience modulates the penetrance of Parkinson's disease genetic risk factors.
    Ann Neurol. 2022 May 22. doi: 10.1002/ana.26416.
    PubMed         Abstract available

  2. HUANG Y, Liu Z, Li N, Tian C, et al
    Parkinson's disease derived exosomes aggravate neuropathology in SNCA*A53T mice.
    Ann Neurol. 2022 May 21. doi: 10.1002/ana.26421.
    PubMed         Abstract available

    BMC Neurol

  3. NISHIMURA Y, Tsuboi H, Murata KY, Minoshima Y, et al
    Comparison of erector spinae fatigability between female patients with Parkinson's disease and healthy individuals: a cross sectional pilot study.
    BMC Neurol. 2022;22:189.
    PubMed         Abstract available

    Int J Neurosci

  4. DIAS CMV, Leal DA, Brys I
    Levodopa-induced dyskinesia is preceded by increased levels of anxiety and motor impairment in Parkinson's disease patients.
    Int J Neurosci. 2022 May 23:1-10. doi: 10.1080/00207454.2022.2079501.
    PubMed         Abstract available

    J Neural Transm (Vienna)

  5. REICHMANN H, Csoti I, Koschel J, Lorenzl S, et al
    Life style and Parkinson's disease.
    J Neural Transm (Vienna). 2022 May 23. pii: 10.1007/s00702-022-02509.
    PubMed         Abstract available

    J Neurosci

  6. MORIARTY N, Kauhausen JA, Pavan C, Hunt CP, et al
    Understanding the influence of target acquisition on survival, integration and phenotypic maturation of dopamine neurons within stem cell-derived neural grafts in a Parkinson's disease model.
    J Neurosci. 2022 May 23. pii: JNEUROSCI.2431-21.2022.
    PubMed         Abstract available

    Mov Disord

  7. GAURAV R, Pyatigorskaya N, Biondetti E, Valabregue R, et al
    Deep Learning-Based Neuromelanin MRI Changes of Isolated REM Sleep Behavior Disorder.
    Mov Disord. 2022;37:1064-1069.
    PubMed         Abstract available

  8. TODISCO M, Cosentino G, Scardina S, Fresia M, et al
    Diagnostic and Prognostic Value of External Anal Sphincter EMG Patterns in Multiple System Atrophy.
    Mov Disord. 2022;37:1069-1074.
    PubMed         Abstract available

  9. GANAPATHY S R, Levova K, Kotackova L, Trnka J, et al
    Increased Transferrin Sialylation Predicts Phenoconversion in Isolated REM Sleep Behavior Disorder.
    Mov Disord. 2022;37:983-992.
    PubMed         Abstract available

  10. ALZGHOOL OM, van Dongen G, van de Giessen E, Schoonmade L, et al
    alpha-Synuclein Radiotracer Development and In Vivo Imaging: Recent Advancements and New Perspectives.
    Mov Disord. 2022;37:936-948.
    PubMed         Abstract available

  11. KIM R, Kim HJ, Shin JH, Lee CY, et al
    Serum Inflammatory Markers and Progression of Nonmotor Symptoms in Early Parkinson's Disease.
    Mov Disord. 2022 May 21. doi: 10.1002/mds.29056.
    PubMed         Abstract available

  12. YANG X, Ai P, He X, Mo C, et al
    Parkinson's Disease Is Associated with Impaired Gut-Blood Barrier for Short-Chain Fatty Acids.
    Mov Disord. 2022 May 24. doi: 10.1002/mds.29063.
    PubMed         Abstract available

  13. DU G, Wang E, Sica C, Chen H, et al
    Dynamics of Nigral Iron Accumulation in Parkinson's Disease: From Diagnosis to Late Stage.
    Mov Disord. 2022 May 25. doi: 10.1002/mds.29062.
    PubMed         Abstract available

  14. LI C, Hou Y, Ou R, Gu X, et al
    Genetic Determinants of Survival in Parkinson's Disease in the Asian Population.
    Mov Disord. 2022 May 26. doi: 10.1002/mds.29069.
    PubMed         Abstract available

    Neurobiol Dis

  15. ABDI IY, Ghanem SS, El-Agnaf OM
    Immune-related biomarkers for Parkinson's disease.
    Neurobiol Dis. 2022;170:105771.
    PubMed         Abstract available

    Neurochem Res

  16. NGUYEN TT, Bao NS, Van Vo G
    Advances in Hydrogel-Based Drug Delivery Systems for Parkinson's Disease.
    Neurochem Res. 2022 May 20. pii: 10.1007/s11064-022-03617.
    PubMed         Abstract available

  17. CHEN Y, Li YY, Wang S, Zhou T, et al
    Ginsenoside Rg1 Plays a Neuroprotective Role in Regulating the Iron-Regulated Proteins and Against Lipid Peroxidation in Oligodendrocytes.
    Neurochem Res. 2022;47:1721-1735.
    PubMed         Abstract available

  18. TYAGI S, Shekhar N, Thakur AK
    Protective Role of Capsaicin in Neurological Disorders: An Overview.
    Neurochem Res. 2022;47:1513-1531.
    PubMed         Abstract available

  19. USTUNDAG FD, Unal I, Ustundag UV, Cansiz D, et al
    3-Pyridinylboronic Acid Ameliorates Rotenone-Induced Oxidative Stress Through Nrf2 Target Genes in Zebrafish Embryos.
    Neurochem Res. 2022;47:1553-1564.
    PubMed         Abstract available


  20. GROVER S, Ashwin AKS, Pihlstrom L, Domenighetti C, et al
    Genome-wide Association and Meta-analysis of Age-at-Onset in Parkinson Disease: Evidence From COURAGE-PD Consortium.
    Neurology. 2022 May 26. pii: WNL.0000000000200699.
    PubMed         Abstract available

    Neurosci Lett

  21. WANG LX, Liu C, Shao YQ, Jin H, et al
    Peripheral Blood Inflammatory Cytokines are Associated with Rapid Eye Movement Sleep Behavior Disorder in Parkinson's Disease.
    Neurosci Lett. 2022 May 20:136692. doi: 10.1016/j.neulet.2022.136692.
    PubMed         Abstract available

    PLoS One

  22. HILL A, Nantel J
    Sensitivity of discrete symmetry metrics: Implications for metric choice.
    PLoS One. 2022;17:e0268581.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Parkinson's Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.